Australia markets closed

BioNeutra Global Corporation (BGA.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.10000.0000 (0.00%)
At close: 12:04PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 4.67M
Enterprise value 10.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.41
Price/book (mrq)N/A
Enterprise value/revenue 0.92
Enterprise value/EBITDA -29.61

Trading information

Stock price history

Beta (5Y monthly) 1.93
52-week change 3566.67%
S&P500 52-week change 325.59%
52-week high 30.1600
52-week low 30.0050
50-day moving average 30.1095
200-day moving average 30.0548

Share statistics

Avg vol (3-month) 38.49k
Avg vol (10-day) 3100
Shares outstanding 546.7M
Implied shares outstanding 646.7M
Float 829.48M
% held by insiders 136.52%
% held by institutions 10.00%
Shares short (30 Apr 2024) 4237
Short ratio (30 Apr 2024) 40.09
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.00%
Shares short (prior month 28 Mar 2024) 42.16k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -18.52%
Operating margin (ttm)38.11%

Management effectiveness

Return on assets (ttm)-3.87%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)11.38M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)N/A
EBITDA -41.67k
Net income avi to common (ttm)-2.11M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.89M
Total cash per share (mrq)0.04
Total debt (mrq)7.64M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.47
Book value per share (mrq)-0.13

Cash flow statement

Operating cash flow (ttm)683.42k
Levered free cash flow (ttm)1.61M